Financing Drugs in South-East Asia - Report of the First Meeting of the WHO/SEARO Working Group on Drug Financing, Korat, Thailand, 26-28 November 1996 - Health Economics and Drugs Series No. 004
(1997; 72 pages) Ver el documento en el formato PDF
Índice de contenido
Abrir esta carpeta y ver su contenidoExecutive summary
Abrir esta carpeta y ver su contenido1. Introduction
Abrir esta carpeta y ver su contenido2. Country presentations on drug financing
Abrir esta carpeta y ver su contenido3. Korat provincial field visit
Abrir esta carpeta y ver su contenido4. Drug financing issues
Abrir esta carpeta y ver su contenido5. Country priorities for drug financing
Abrir esta carpeta y ver su contenido6. Priorities for work group action
Abrir esta carpeta y ver su contenido7. Conclusions and recommendations
Ver el documentoAnnex A. Agenda
Ver el documentoAnnex B. List of participants
Ver el documentoAnnex C. List of documents
Ver el documentoAnnex D. Message from Regional Director, WHO South-East Asia Region
Abrir esta carpeta y ver su contenidoAnnex E. Evaluation of the meeting. Priorities for the Working Group
 

Annex A. Agenda

26 November 1996

08.00 - 9.00:

Registration

09.00 - 10.00:

Opening session

Welcome by the Deputy Secretary-General, FDA, Ministry of Public Health
Message from the Regional Director, WHO Regional Office for South-East Asia
Statement by Dr Jonathan Quick, Director, DAP/WHO/HQ
Introduction of participants
Nomination of Chairperson, Co-chairperson & Rapporteur
Background and objectives of the meeting (Dr Kin Shein, WHO/SEARO)
Administrative announcements:
(Ms. Suboonya Hutangkabodee, Director Technical Division, FDA)

10.00 - 10.30:

Group photograph, followed by coffee/tea break

10.30 - 12.00:

Drug financing situation: 3 country presentations
(15 minutes/country)

-Country participants:

* Thailand
* Nepal
* Myanmar
* Objectives of field visit: Dr Jonathan Quick

12.00 - 13.00:

Lunch

13.00:

Depart hotel for field visit

13.30 - 17.00:

Field visit to: Soongnern Hospital
Health centre
Village drug fund
Debriefing at hospital

27 November 1996, Wednesday

8.30 - 9.30:

Review of major observations from first day

9.30 - 10.00:

Country presentation - Indonesia

10.00 - 10.30:

Coffee/tea break

10.30 - 11.30:

Drug financing strategies: Dr German Velasquez
(Presentation and discussions)

11.30 - 12.30:

Cost-sharing for drugs: Dr Petcharat Pongcharoensuk
(Presentation and discussions)

12.30 - 13.30:

Lunch

13.30 - 15.30:

Country priorities for workgroup action:
Dr Jonathan Quick, Dr German Velasquez
(Discussions and presentations, four groups)

15.30 - 16.00:

Coffee/tea break

16.00 - 17.00:

Monitoring for equity and quality: Dr Jonathan Quick
(Presentation and discussions)

28 November 1996

8.30 - 10.00:

Priorities for Working Group action
(Discussions, two work groups)

10.00 - 10.30:

Coffee/tea break

10.30 - 12.30:

Report from work group and discussions

12.30 - 13.30:

Lunch

13.30 - 14.30:

Country priorities for action (four work groups)
Health and drug financing indicators (four work groups)

14.30 - 15.00:

Presentation of country priorities for action

15.00 - 15.15:

Presentation of health and drug financing indicators:
Dr Jonathan Quick

15.15 - 15.30:

Evaluations and recommendations

15 30 - 16.00:

Next meeting, timing, venue and closing of meeting.

 

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013